NEOPLASMS BY HISTOLOGIC TYPE
Clinical trials for NEOPLASMS BY HISTOLOGIC TYPE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY HISTOLOGIC TYPE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY HISTOLOGIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug cut surgeries for rare throat condition?
Disease control OngoingThis study tests if bevacizumab, a drug that blocks blood vessel growth, can help adults with recurrent respiratory papillomatosis (RRP) go longer between surgeries to remove wart-like growths in their airways. About 21 participants who need at least two surgeries per year will r…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC
-
Engineered immune cells aim to stop lymphoma relapse after transplant
Disease control OngoingThis early-phase study tests a treatment that adds a special antibody to a patient's own immune cells (T cells) to help them find and attack lymphoma cells. The goal is to find a safe dose of these modified cells to give after a stem cell transplant, to try to prevent the cancer …
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Engineered immune cells take aim at Hard-to-Treat lymphomas
Disease control OngoingThis study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard therapies. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack cancer cells carrying a marker…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) or radiation therapy (IMRT). It looks at which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking part. The goal i…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated May 27, 2026 23:06 UTC